Jan Konvalinka

Jan Konvalinka is a prominent Czech biochemist and director of the Institute of Organic Chemistry and Biochemistry at the Czech Academy of Sciences. He has made significant contributions to the field of virology, particularly in the development of antiviral therapies. Recently, he gained attention for his role in explaining the innovative mechanism of the HIV prevention drug Lenacapavir, which blocks the viral capsid protein, preventing the proper assembly of viral particles.